NASDAQ:LIVN

LivaNova (LIVN) Stock Price, News & Analysis

LivaNova logo
$94.54 +2.62 (+2.85%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$95.23 +0.69 (+0.73%)
As of 11/18/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About LivaNova Stock (NASDAQ:LIVN)

Advanced

Key Stats

Today's Range
$90.20
▼
$95.40
50-Day Range
$74.70
▼
$94.54
52-Week Range
$53.37
▼
$99.38
Volume
1.32 million shs
Average Volume
782,874 shs
Market Capitalization
$5.21 billion
P/E Ratio
25.18
Dividend Yield
N/A
Price Target
$101.22
Consensus Rating
Moderate Buy

Company Overview

LivaNova plc is a global medical technology company that develops and manufactures products for cardiovascular care and neuromodulation. The company was formed in 2015 through the combination of Cyberonics and Sorin Group.

In neuromodulation, LivaNova’s VNS Therapy system delivers vagus nerve stimulation and is used as an adjunctive treatment for certain people with drug-resistant epilepsy and treatment-resistant depression. Its cardiovascular products support cardiac surgery and include heart-lung machines, oxygenators and related perfusion equipment.

LivaNova serves healthcare providers and patients in markets around the world, with products used in hospitals and other clinical settings.

AI Generated. May Contain Errors.

LivaNova Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

LIVN MarketRank™: 
2.110004094445 of 5 stars

LivaNova scored higher than 42% of companies evaluated by MarketBeat, and ranked 1223rd out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LivaNova has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 9 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for LivaNova is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    LivaNova has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about LivaNova's stock forecast and price target.
  • Earnings Growth

    Earnings for LivaNova are expected to grow by 12.23% in the coming year, from $3.76 to $4.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LivaNova is 25.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LivaNova is 25.18, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.52.

  • Price to Book Value per Share Ratio

    LivaNova has a P/B Ratio of 3.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    11.59% of the float of LivaNova has been sold short.
  • Short Interest Ratio / Days to Cover

    LivaNova has a short interest ratio ("days to cover") of 12.42, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in LivaNova has recently increased by 2.63%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    LivaNova does not currently pay a dividend.

  • Dividend Growth

    LivaNova does not have a long track record of dividend growth.

  • News Sentiment

    LivaNova has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for LivaNova this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for LIVN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LivaNova insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $819,114.00 in company stock.

  • Percentage Held by Insiders

    0.35% of the stock of LivaNova is held by insiders.

  • Percentage Held by Institutions

    97.64% of the stock of LivaNova is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LivaNova's insider trading history.
Receive LIVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LivaNova and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LIVN Stock News Headlines

Medical costs are crushing insurers—and lifting LivaNova stock
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
LivaNova Earnings Call Signals Strong Growth Ahead
See More Headlines

LIVN Stock Analysis - Frequently Asked Questions

LivaNova's stock was trading at $61.53 at the beginning of 2026. Since then, LIVN shares have increased by 53.6% and is now trading at $94.54.

LivaNova PLC (NASDAQ:LIVN) posted its quarterly earnings data on Wednesday, November, 4th. The company reported $1.23 EPS for the quarter, topping analysts' consensus estimates of $1.06 by $0.17. The firm's revenue was up 9.9% compared to the same quarter last year.
Read the conference call transcript
.

LivaNova's top institutional shareholders include State Street Corp (3.93%), Congress Asset Management Co. (2.73%), Bellevue Group AG (0.30%) and CSM Advisors LLC (0.25%). Insiders that own company stock include Alex Shvartsburg, Daniel Jeffrey Moore, Brooke Story and Francesco Bianchi.
View institutional ownership trends
.

Shares of LIVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LivaNova investors own include GE Aerospace (GE), Kinder Morgan (KMI), Wells Fargo & Company (WFC), Exact Sciences (EXAS), Diamondback Energy (FANG), Genocea Biosciences (GNCA) and Incyte (INCY).

Company Calendar

Last Earnings
11/04/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:LIVN
CIK
1639691
Employees
3,300
Year Founded
2015

Price Target and Rating

High Price Target
$120.00
Low Price Target
$66.00
Potential Upside/Downside
+7.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.00
Trailing P/E Ratio
25.18
Forward P/E Ratio
22.40
P/E Growth
N/A
Net Income
-$242.47 million
Net Margins
13.01%
Pretax Margin
7.99%
Return on Equity
16.10%
Return on Assets
7.85%

Debt

Debt-to-Equity Ratio
0.22
Current Ratio
1.46
Quick Ratio
1.22

Sales & Book Value

Annual Sales
$1.39 billion
Price / Sales
3.75
Cash Flow
$4.97 per share
Price / Cash Flow
19.01
Book Value
$24.91 per share
Price / Book
3.80

Miscellaneous

Outstanding Shares
55,090,000
Free Float
54,894,000
Market Cap
$5.21 billion
Optionable
Optionable
Beta
0.91

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:LIVN) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners